ketanserin has been researched along with Pneumonia, Viral in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuindersma, M | 1 |
| Spronk, PE | 1 |
1 other study available for ketanserin and Pneumonia, Viral
| Article | Year |
|---|---|
Ketanserin as potential additive drug to improve V/Q mismatch in COVID-19?
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ketanserin; Lung; Pandemics; Pneumonia, V | 2020 |